View Older Stories View More Recent Stories
-
GT Gold Asserts Continued Commitment to Maximizing Value for Shareholders and Comments on K2 Principal Fund News Release
-
Nord Gold S.E. Off-Market Bid – Take No Action
-
Bank of Montreal Announces Quarterly Coupon Amount for the Dorsey Wright MLP Index ETN
-
BMO Employees Rally Together to Combat Economic and Social Disparity
-
Granite REIT Completes Offering of C$500 Million 2.378% Senior Debentures Due 2030
-
BMO Financial Group 2020 Sustainability Report and Public Accountability Statement Now Available Online
-
Nord Gold SE Upcoming Off-Market Bid and Expiry of On-Market Bid
-
BMO Capital Downgrades Aurora Cannabis (ACB:CN) (ACB) to Underperform
-
Horizon Therapeutics (HZNP) Tepezza Shortage 'Seems Manageable' - BMO
-
Phathom Pharmaceuticals Inc. (PHAT) Prices 2.25M Share Common Offering at $42/Sh
-
Atalaya Mining PLC Announces Issue of Equity
-
Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Phathom Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Analysis-U.S. currency manipulator tag for Switzerland unlikely to deter FX approach
-
BMO Financial Group Recognized by CDP for Best Practice in Climate Change
-
UPDATE: BMO Capital Upgrades Sociedad Quimica y Minera (SQM) to Outperform
-
Arvinas Inc. (ARVN) Prices 5.714M Share Common Offering at $70/Sh
-
Analysis-U.S. currency manipulator tag for Switzerland unlikely to deter FX approach
-
AbCellera Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
-
Arvinas, Inc. Announces Pricing of $400 Million Public Offering of Common Stock
-
Protagonist Therapeutics, Inc. Announces Closing of $115 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Pebblebrook Hotel Trust Announces Exercise In Full of Underwriters’ Over-allotment Option and Subsequent Closing of Public Offering of 1.75% Convertible Senior Notes Due 2026
-
Phathom Pharmaceuticals Inc. (PHAT) Announces Proposed 2.5M Common Share Offering
-
Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
-
Phathom Pharmaceuticals Announces Proposed Public Offering of 2,250,000 Shares of Common Stock
-
Atalaya Mining PLC Announces Directorate Change
-
American Finance Trust Prices Public Offering of 3,200,000 Shares of 7.375% Series C Cumulative Redeemable Perpetual Preferred Stock
-
Nortech Systems, Inc. (NSYS) Named Phil Smith and Dan Sachs to the Board
-
Nortech Systems Announces Two New Board Members
-
Arvinas Inc. (ARVN) PT Raised to 'Street High' $114 at BMO Capital
-
S&P 500 ends down, Walt Disney weighs
-
Goldman Sachs (GS) Merchant Banking to Acquire Canada's People Corporation for C$1.13B
-
American Finance Trust Announces Offering of Series C Cumulative Redeemable Perpetual Preferred Stock
-
fuboTV (FUBO) PT Raised to $33 at BMO Capital Following Meetings; Positive on Sports Betting
-
BMO Capital Downgrades Walt Disney (DIS) to Market Perform; Now Comes the Hard Part
-
AbCellera Biologics (ABCL) IPO Opens 205% Higher
-
Increased On‐Market Takeover Bid by Nord Gold SE - Take No Action
-
Costco Wholesale (COST) PT Raised to $430 at BMO Capital
-
Pebblebrook Hotel Trust Prices Public Offering of 1.75% Convertible Senior Notes Due 2026
-
AbCellera Biologics Inc. (ABCL) Prices 24.150M Share IPO at $20/Sh
-
Protagonist Therapeutics (PTGX) Prices 4.76M Share Common Offering at $21/Sh
-
Jadestone Energy Inc. Announces Closing of the Lemang PSC Acquisition
-
Protagonist Therapeutics, Inc. Announces Pricing of $100 Million Public Offering of Common Stock
-
AbCellera Announces Pricing of Initial Public Offering
-
FSK Completes Offering of $1,000,000,000 3.400% Notes Due 2026
-
Votorantim Cimentos and McInnis Cement to Combine Cement Operations in North America
-
BMO Capital Markets Named Best Canadian Bank for USD/CAD for 10th Consecutive Year
-
Fiserv Inc (FISV) Prices Secondary Offering of Common Stock by New Omaha Holdings and Associated Repurchase of its Common Stock
-
Protagonist Therapeutics (PTGX) Announces $100M Proposed Public Offering of Common Stock

